Because the star performers tend to be fairly specialised, covering areas like China, property or Latin America, they are never likely toreceive the biggest fund flows.
However, if patents to protect these discoveries are used to restrict other applications involving the same genes then many promising ideas for new treatments may neverreceive the investor support necessary to develop them and we will all be worse off.